BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 15690658)

  • 1. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
    Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
    Bouma G; Oudkerk Pool M; Crusius JB; Schreuder GM; Hellemans HP; Meijer BU; Kostense PJ; Giphart MJ; Meuwissen SG; Peña AS
    Clin Exp Immunol; 1997 Jul; 109(1):175-9. PubMed ID: 9218841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany.
    Reinshagen M; Loeliger C; Kuehnl P; Weiss U; Manfras BJ; Adler G; Boehm BO
    Gut; 1996 Apr; 38(4):538-42. PubMed ID: 8707084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
    Cleynen I; Boucher G; Jostins L; Schumm LP; Zeissig S; Ahmad T; Andersen V; Andrews JM; Annese V; Brand S; Brant SR; Cho JH; Daly MJ; Dubinsky M; Duerr RH; Ferguson LR; Franke A; Gearry RB; Goyette P; Hakonarson H; Halfvarson J; Hov JR; Huang H; Kennedy NA; Kupcinskas L; Lawrance IC; Lee JC; Satsangi J; Schreiber S; Théâtre E; van der Meulen-de Jong AE; Weersma RK; Wilson DC; ; Parkes M; Vermeire S; Rioux JD; Mansfield J; Silverberg MS; Radford-Smith G; McGovern DP; Barrett JC; Lees CW
    Lancet; 2016 Jan; 387(10014):156-67. PubMed ID: 26490195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease.
    Silverberg MS; Mirea L; Bull SB; Murphy JE; Steinhart AH; Greenberg GR; McLeod RS; Cohen Z; Wade JA; Siminovitch KA
    Inflamm Bowel Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12656131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
    Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
    Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga-Domínguez L; Lopez-Martinez A; Granados J
    World J Gastroenterol; 2006 Mar; 12(10):1617-20. PubMed ID: 16570357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele.
    Forcione DG; Sands B; Isselbacher KJ; Rustgi A; Podolsky DK; Pillai S
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5094-8. PubMed ID: 8643533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II alleles in Japanese patients with inflammatory bowel disease.
    Yoshitake S; Kimura A; Okada M; Yao T; Sasazuki T
    Tissue Antigens; 1999 Apr; 53(4 Pt 1):350-8. PubMed ID: 10323339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Kim BG; Kim YS; Kim JS; Jung HC; Song IS
    Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease.
    Bernstein CN; Orr K; Blanchard JF; Sargent M; Workman D
    Can J Gastroenterol; 2001 Aug; 15(8):499-504. PubMed ID: 11544532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis.
    Stokkers PC; Reitsma PH; Tytgat GN; van Deventer SJ
    Gut; 1999 Sep; 45(3):395-401. PubMed ID: 10446108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
    Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.